Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine Date Wednesday, September 22, 2021 - 6:00 PM Description
Effectiveness of mRNA Covid-19 Vaccine among U.S. Health Care Personnel Date Wednesday, September 22, 2021 - 8:00 AM Description
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase Date Wednesday, September 22, 2021 - 8:00 AM Description
Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting Date Wednesday, September 15, 2021 - 6:00 PM Description
SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3 Date Wednesday, September 15, 2021 - 8:00 AM Description
Challenges of Sarcoidosis and Its Management Date Wednesday, September 08, 2021 - 6:00 PM Description
Receipt of mRNA Covid-19 Vaccines and Risk of Spontaneous Abortion Date Wednesday, September 08, 2021 - 8:00 AM Description
Effect of Vaccination on Transmission of SARS-CoV-2 Date Wednesday, September 08, 2021 - 8:00 AM Description
